General
Preferred name
SALIDROSIDE
Synonyms
Salidroside (Rhodioloside) ()
Rhodioloside ()
P&D ID
PD000379
CAS
10338-51-9
Tags
available
natural product
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Salidroside is a plant-derived glycoside. It is suggested to exhibit antioxidant, anti-inflammatory and neuroprotective effects. Its mechanism of action is not fully resolved, but is reported to include monoamine oxidase B inhibition .
(GtoPdb)
DESCRIPTION
Salidroside (Rhodioloside) is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
3
Organisms
0
Compound Sets
7
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
Drug Repurposing Hub
Guide to Pharmacology
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
37
Molecular Weight
300.12
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
5
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
1
cLogP
-1.25
TPSA
119.61
Fraction CSP3
0.57
Chiral centers
5.0
Largest ring
6.0
QED
0.46
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Apoptosis
MTOR
PINK1/Parkin
Prolyl Endopeptidase (PREP)
APP
Mitophagy,mTOR,PREP
MOA
mTOR
beta amyloid protein neurotoxicity inhibitor
Pathway
Autophagy
Metabolic Enzyme/Protease
Neuronal Signaling
PI3K/Akt/mTOR
Source data

